VEREKITUG
UNII T1NAO7YDA7

Substance Identification & Data

This profile provides standardized clinical and technical data for Verekitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T1NAO7YDA7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2768386-15-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T1NAO7YDA7

CAS Registry Number

2768386-15-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VEREKITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203156

National Cancer Institute reference terminology for clinical and research data.

INN ID

12749

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-173

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Verekitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VEREKITUG

Common Names & Synonyms

ASP7266 (HUMAN MONOCLONAL IGG1 AGAINST THYMIC STROMAL LYMPHOPOIETIN RECEPTOR (TSLPR))

IMMUNOGLOBULIN G1, ANTI-(HUMAN AND MACACA FASCICULARIS CYTOKINE RECEPTOR-LIKE FACTOR 2) (HUMAN MONOCLONAL UPB-101 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL UPB-101 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CRLF2 (CYTOKINE RECEPTOR LIKE FACTOR 2, TSLPR, THYMIC STROMAL LYMPHOPOIETIN RECEPTOR)), HOMO SAPIENS MONOCLONAL ANTIBODY

VEREKITUG [INN]

VEREKITUG [USAN]